Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade!

Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications.

Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents.

In 2022, Carroucell advanced adherent cell production's supply chain with efficient scaffolds like Flexi GrowTM microcarriers, significantly increasing culture yield while preserving cell quality.

As the visionary behind the new Microcarrier generation, Carroucell ensures heightened productivity through a distinctive warranty and a Charter commitment statement.

Carroucell prioritizes Good Manufacturing Practices (GMP) for comprehensive clinical trial support, adhering strictly to GMP guidelines, elevating product reliability and integrity for researchers and clinicians in trials.